Abstract
This paper covers the economic effects of health care reform on innovation in the pharmaceutical industry. The pharmaceutical industry must help create the change reform will bring, recognizing the exigencies of the marketplace. It must focus on value, in the form of pharmacoeconomics and outcomes research. Innovation will be reduced in magnitude, but made more effective. Pharmaceutical research and development will be reorganized to focus on managed care.
Get full access to this article
View all access options for this article.